Drug Profile
Research programme: stem cell therapies - Creative Medical Health
Latest Information Update: 27 Dec 2022
Price :
$50
*
At a glance
- Originator MediStem Laboratories; Russian Academy of Sciences
- Developer CREATIVE MEDICAL HEALTH
- Class Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cardiovascular disorders; Diabetes mellitus; Erectile dysfunction; Female sexual dysfunction; Multiple sclerosis; Neurological disorders; Primary ovarian insufficiency; Spinal cord injuries
Most Recent Events
- 27 Dec 2022 Discontinued for Cardiovascular disorders in USA (Parenteral)
- 27 Dec 2022 Discontinued for Diabetes mellitus in USA (Parenteral)
- 27 Dec 2022 Discontinued for Erectile dysfunction in USA (Parenteral)